A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine

被引:0
|
作者
Rachel L. Gross
Jason Brucker
Asena Bahce-Altuntas
Maria A. Abadi
Jules Lipoff
David Kotlyar
Peter Barland
Chaim Putterman
机构
[1] Albert Einstein College of Medicine,Division of Rheumatology, Department of Medicine
[2] Jacobi Medical Center,Department of Pathology
[3] Albert Einstein College of Medicine,Department of Dermatology
[4] Montefiore Medical Center,Department of Medicine
[5] Albert Einstein College of Medicine,Department of Microbiology & Immunology
来源
Clinical Rheumatology | 2011年 / 30卷
关键词
Cocaine; Levamisole; Retiform purpura; Vasculitis;
D O I
暂无
中图分类号
学科分类号
摘要
In order to describe the clinical and serologic features of a cutaneous vasculitis due to cocaine contaminated with the adulterant levamisole, we report four new cases of this syndrome along with 12 previously reported cases identified through a PubMed Literature search (1964 to March 2011). Of the 16 patients described, the average age was 43, with a female predominance (81% of patients). Over half of patients had involvement of the earlobes, and the rash frequently affected the extremities in a “retiform” pattern. Leukopenia or neutropenia was reported in 56% of patients. Ninety-three percent were anti-neutrophil cytoplasmic antibody positive, and 63% tested positive for anti-phospholipid antibodies. The predominant pattern seen on histopathological examination of the skin was small vessel vasculitis and/or a thrombotic vasculopathy. Treatment in these patients varied widely, with several patients showing improvement or resolution of the rash without specific therapy following cessation of illicit drug use. This new cutaneous vasculitis syndrome can be recognized by its characteristic rash and skin pathology, together with leukopenia and autoantibody production. Certain clinical features can be attributed to the adulterant levamisole, though cocaine as well may play a role in its pathogenesis.
引用
收藏
页码:1385 / 1392
页数:7
相关论文
共 50 条
  • [21] Cutaneous vasculitis secondary to levamisole treatment in the nephrotic syndrome in paediatrics
    Bernaldo, Felix Sanchez
    Mancheno, Beatriz Bravo
    Morales, Ana Maria Ortega
    Perez, Maria Belen Sevilla
    Llorente, Maria Amelia Gomez
    ARS PHARMACEUTICA, 2024, 65 (04) : 374 - 378
  • [22] Levamisole-induced occlusive necrotising vasculitis in cocaine abusers: an unusual cause of skin necrosis and neutropenia
    Belfonte, Cassius D.
    Shanmugam, Victoria K.
    Kieffer, Nicole
    Coker, Shodeinde
    Boucree, Suelyn
    Kerr, Gail
    INTERNATIONAL WOUND JOURNAL, 2013, 10 (05) : 590 - 596
  • [23] Agranulocytosis and vasculitis in a cocaine addict: Levamisole, the hidden culprit
    Lemaignen, A.
    Goulenok, T.
    Kalamarides, S.
    Plat, A.
    Pfau, G.
    Fantin, B.
    REVUE DE MEDECINE INTERNE, 2014, 35 (10): : 676 - 679
  • [24] Levamisole-induced vasculitis
    George, Tonya C.
    Freet, Daniel J.
    Cross, James M.
    Huzar, Todd F.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (01): : 23 - 27
  • [25] Cocaine-Induced Vasculitis
    Berman, Mark
    Paran, Daphna
    Elkayam, Ori
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2016, 7 (04):
  • [26] Elevated C-reactive Protein and Role of Steroids in Cocaine-associated Levamisole-induced Vasculitis
    Alexander, Swetha Ann
    Thomas, Vinay Mathew
    Savage, Jacqueline A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (04)
  • [27] Cocaine Use and Levamisole-Induced Vasculitis A Multiple Case Study
    Engels, Dawn
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2020, 47 (02) : 182 - 189
  • [28] Pulmonary-Renal Syndrome from Levamisole-Adulterated Cocaine-Induced Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Systematic Review
    Bucur, Philip
    Weber, Marshall
    Agrawal, Rashi
    Madera-Acosta, Adria Irina
    Elam, Rachel E. E.
    PHARMACEUTICALS, 2023, 16 (06)
  • [30] Cutaneous Vasculopathy Associated with Levamisole-Adulterated Cocaine
    Tran, Huy
    Tan, Debbie
    Marnejon, Thomas
    CLINICAL MEDICINE & RESEARCH, 2013, 11 (01) : 26 - 30